ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,649Medicare Part D Prescriptions Filled, Including Refills

Rank: 110 out of 1000

$777K Total Retail Price of All Prescriptions

Rank: 114 out of 1000

461 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 461 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 461 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 13,433 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
LISINOPRIL 830 665 1 5
SIMVASTATIN 668 522 2 3
OMEPRAZOLE 612 502 3 2
FUROSEMIDE 589 508 4 7
AMLODIPINE BESYLATE 521 389 5 6
LEVOTHYROXINE SODIUM 508 448 6 4
WARFARIN SODIUM 481 391 7 22
POTASSIUM CHLORIDE 353 340 8 10
METFORMIN HCL 332 231 9 8
PRAVASTATIN SODIUM 306 225 10 12
METOPROLOL TARTRATE 301 239 11 19
MELOXICAM 258 210 12 14
GABAPENTIN 252 194 13 11
NEXIUM 222 166 14 23
HYDROCODONE-ACETAMINOPHEN 218 202 S3 15 1
METOPROLOL SUCCINATE 215 185 16 21
CARVEDILOL 214 175 17 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 198 145 18 20
ATENOLOL 184 139 19 24
HYDROCHLOROTHIAZIDE 182 165 20 9
LANTUS 181 139 21 68
METFORMIN HCL ER 171 118 22 44
RANITIDINE HCL 161 144 23 37
CRESTOR 156 117 24 30
TRAMADOL HCL 148 136 25 13
CITALOPRAM HBR 143 109 26 17
NAMENDA 135 122 27 43
DONEPEZIL HCL 135 128 27 32
AZITHROMYCIN 132 111 29 36
CLOTRIMAZOLE-BETAMETHASONE 130 126 30 173
ATORVASTATIN CALCIUM 128 97 31 18
CLOPIDOGREL 127 103 32 35
DIGOXIN 123 105 33 52
ISOSORBIDE MONONITRATE ER 120 106 34 71
MUPIROCIN 116 99 35 140
NOVOLIN R 112 81 36 185
ENALAPRIL MALEATE 109 96 37 58
PANTOPRAZOLE SODIUM 105 105 38 28
FAMOTIDINE 105 72 38 88
CEPHALEXIN 101 74 40 90
TRIAMTERENE-HCTZ 101 66 40 48
SERTRALINE HCL 101 77 40 26
HYDRALAZINE HCL 100 84 43 74
GLYBURIDE MICRONIZED 97 64 R 44 261
LOSARTAN POTASSIUM 91 50 45 25
MEGESTROL ACETATE 89 85 R 46 134
OXYBUTYNIN CHLORIDE 86 82 47 145
CLONIDINE HCL 84 53 48 27
CYCLOBENZAPRINE HCL 84 56 R 48 39
POLYETHYLENE GLYCOL 3350 83 26 50 69
EXELON 79 79 51 108
PLAVIX 79 58 51 49
SPIRIVA 75 49 53 64
LANTUS SOLOSTAR 74 55 54 120
ADVAIR DISKUS 74 55 54 65
NOVOLIN 70-30 73 38 56 160
LEVETIRACETAM 73 54 56 128
JANUVIA 72 41 58 85
PEN NEEDLE 72 49 58 165
DIOVAN 70 49 60 67
GLYBURIDE 69 65 R 61 92
QUETIAPINE FUMARATE 67 56 62 75
BUSPIRONE HCL 66 45 63 110
AMIODARONE HCL 63 63 64 178
PAROXETINE HCL 62 48 65 63
TAMSULOSIN HCL 61 47 66 33
TRAZODONE HCL 60 42 67 29
FENOFIBRATE 60 29 67 55
PROAIR HFA 60 38 67 50
SUCRALFATE 60 59 67 144
DILTIAZEM 24HR CD 60 48 67 136
CIPROFLOXACIN HCL 59 51 72 46
FLUTICASONE PROPIONATE 58 35 73 40
ZOLPIDEM TARTRATE 57 53 74 16
ALLOPURINOL 56 45 75 31
ALENDRONATE SODIUM 56 56 75 57
LEVEMIR FLEXPEN 55 23 77 205
AMOXICILLIN 55 47 77 89
SPIRONOLACTONE 53 47 79 78
LYRICA 52 42 80 47
PHENYTOIN SODIUM EXTENDED 52 41 80 115
RISPERIDONE 52 50 80 87
NITROGLYCERIN PATCH 51 51 83 226
LACTULOSE 50 41 84 162
HUMULIN R 50 34 84 215
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.